Skip to content

Taper-shaped Cuff Endotracheal Tube Against Respiratory Infections

Effect of Endotracheal Tube With Taper-shaped Cuff on Incidence of Postoperative Pneumonia After Aortic Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01457248
Acronym
TETRIS
Enrollment
162
Registered
2011-10-21
Start date
2011-10-31
Completion date
2014-06-30
Last updated
2014-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pneumonia

Keywords

after aortic surgery

Brief summary

The incidence of postoperative pneumonia after aortic surgery reaches 60%. In experimental lung model, endotracheal tube with taper-shaped cuff has been shown to decrease microaspiration. This effect has never been demonstrated in patients. The investigators hypothesize that use of endotracheal tube with taper-shaped cuff decreases the incidence of postoperative pneumonia in patients after aortic surgery.

Interventions

DEVICEEndotracheal tube TaperGuard

Patients are intubated by endotracheal tube with taper-shaped cuff (TaperGuard, Mallinckrodt)

DEVICEEndotracheal tube Hi-Contour Brandt

Patients are intubated by endotracheal tube with cylindrical-shaped cuff (Hi-Contour Brandt, Mallinckrodt)

Sponsors

Association pour la Recherche et la Formation en Anesthésie Analgésie Réanimation
CollaboratorOTHER
Groupe Hospitalier Pitie-Salpetriere
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 ans * Elective aortic surgery * Admission in ICU after aortic surgery

Exclusion criteria

* Tracheostomized patients

Design outcomes

Primary

MeasureTime frame
Incidence of first episode of postoperative pneumonia after aortic surgeryWithin the first 28 days after surgery

Secondary

MeasureTime frame
MicroaspirationDay 1 and day 2
Length of ICU stayParticipants will be followed for the duration of ICU stay, an expected average of 3 weeks
MortalityDay 28 and day 90

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026